Who We Are

Before Brands is a health and wellness company that is developing a series of products targeted at transforming the world's relationship with food allergies. Our proprietary protein blend was developed at Stanford University by a pediatrician, allergist and mother of five.

Science Discerns the Laws of Nature. Industry Applies Them to the Needs of Man. - Museum of Science and Industry (Chicago, Ill.)

Founders

Ashley Dombkowski

Co-Founder and CEO
Ashley Dombkowski, Ph.D. is Co-Founder and CEO of BEFORE Brands™, a consumer-focused product platform focused on health and wellness for parents and families. She co-founded the company in 2015 with Dr. Kari Nadeau, the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She has 20 years of experience as an operating executive, entrepreneur, and investor in fields spanning consumer health and life sciences. Her portfolio of innovative biotechnology, medical device, consumer health and HCIT companies has included 23andMe, Adolor, Alnara, BioVitrum, Epizyme, iPierian, Neosil, Nevro, Rigel, Tercica, and Twist. She previously served as a Managing Director with Bay City Capital, a $1.6B venture capital firm. Prior to that she served as Chief Business Officer and Vice President of Operations for 23andMe, where she oversaw the company’s finance and operations activities and had responsibility for the company’s long term business strategy. Before to joining 23andMe, she was a Managing Director with MPM Capital where she served as a member of the firm’s Investment Committee. Prior to this, she was an Equity Analyst for hedge fund Tiger Management L.L.C. and for institutional asset management firm Dresdner RCM Global Investors. Dr. Dombkowski holds a Ph.D. in Mathematics from Rice University and received her B.A. in Mathematics from Wellesley College. She has been widely quoted in publications ranging from Nature to The Wall Street Journal and she has appeared in media outlets including CNBC, SXSW, and TedMed. She was recognized as one of the 100 Most Influential Women in Business by the San Jose/Silicon Valley Business Journal in 2010. She is a member of the Board of Directors of USA Volleyball, the National Governing Body for all disciplines of Volleyball as recognized by the U.S. Olympic Committee, and serves as Chair of the Audit, Finance, and Budget committee.
Read Less

Kari Nadeau

Co-Founder and Inventor

Kari Nadeau, M.D., Ph.D. is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Her center’s vision is to find the causes and cures of allergies. Her center’s mission is to transform the lives of patients and families through innovative science and compassionate care.

After graduating from Haverford College (summa cum laude) with a degree in biology, Dr. Nadeau attended Harvard Medical School via the Medical Scientist Training Program (NIH), and received a PhD in Biological Chemistry and Molecular Pharmacology and an MD in 1995. She then performed an internship and residency in pediatrics at the Children’s Hospital Boston, Harvard Medical School. From 1998 to 2002, she worked in the field of biopharmaceuticals and led clinical research to obtain FDA approval for two biologics in the field of Autoimmunity and Oncology, respectively. From 2003-2006, Dr. Nadeau was a fellow in Asthma, Allergy and Immunology at the Stanford/UCSF program under Dr. Umetsu. During this time, she also did a postdoctoral fellowship in human immune tolerance mechanisms in asthma and allergy. In 2006, Dr. Nadeau was appointed to the Stanford University School of Medicine with appointments in Pediatrics and Otolaryngology. She enjoys mentoring students, post doctoral candidates, and faculty. She currently holds an endowed faculty position under the Naddisy Family Foundation. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA.  She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology and is a member of ASCI (American Society of Clinical Investigation). She has authored or co-authored more than 110 original papers, and has maintained an interest in the study of immune mechanisms in allergy and asthma for more than 20 years. Her laboratory focuses on the study of immunological mechanisms involved in the cause, diagnosis, and therapy for allergy and asthma.  

Read Less

Ashley Dombkowski

Co-Founder and CEO
Ashley Dombkowski, Ph.D. is Co-Founder and CEO of BEFORE Brands™, a consumer-focused product platform focused on health and wellness for parents and families. She co-founded the company in 2015 with Dr. Kari Nadeau, the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She has 20 years of experience as an operating executive, entrepreneur, and investor in fields spanning consumer health and life sciences. Her portfolio of innovative biotechnology, medical device, consumer health and HCIT companies has included 23andMe, Adolor, Alnara, BioVitrum, Epizyme, iPierian, Neosil, Nevro, Rigel, Tercica, and Twist. She previously served as a Managing Director with Bay City Capital, a $1.6B venture capital firm. Prior to that she served as Chief Business Officer and Vice President of Operations for 23andMe, where she oversaw the company’s finance and operations activities and had responsibility for the company’s long term business strategy. Before to joining 23andMe, she was a Managing Director with MPM Capital where she served as a member of the firm’s Investment Committee. Prior to this, she was an Equity Analyst for hedge fund Tiger Management L.L.C. and for institutional asset management firm Dresdner RCM Global Investors. Dr. Dombkowski holds a Ph.D. in Mathematics from Rice University and received her B.A. in Mathematics from Wellesley College. She has been widely quoted in publications ranging from Nature to The Wall Street Journal and she has appeared in media outlets including CNBC, SXSW, and TedMed. She was recognized as one of the 100 Most Influential Women in Business by the San Jose/Silicon Valley Business Journal in 2010. She is a member of the Board of Directors of USA Volleyball, the National Governing Body for all disciplines of Volleyball as recognized by the U.S. Olympic Committee, and serves as Chair of the Audit, Finance, and Budget committee.
Read Less

Kari Nadeau

Co-Founder and Inventor

Kari Nadeau, M.D., Ph.D. is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Her center’s vision is to find the causes and cures of allergies. Her center’s mission is to transform the lives of patients and families through innovative science and compassionate care.

After graduating from Haverford College (summa cum laude) with a degree in biology, Dr. Nadeau attended Harvard Medical School via the Medical Scientist Training Program (NIH), and received a PhD in Biological Chemistry and Molecular Pharmacology and an MD in 1995. She then performed an internship and residency in pediatrics at the Children’s Hospital Boston, Harvard Medical School. From 1998 to 2002, she worked in the field of biopharmaceuticals and led clinical research to obtain FDA approval for two biologics in the field of Autoimmunity and Oncology, respectively. From 2003-2006, Dr. Nadeau was a fellow in Asthma, Allergy and Immunology at the Stanford/UCSF program under Dr. Umetsu. During this time, she also did a postdoctoral fellowship in human immune tolerance mechanisms in asthma and allergy. In 2006, Dr. Nadeau was appointed to the Stanford University School of Medicine with appointments in Pediatrics and Otolaryngology. She enjoys mentoring students, post doctoral candidates, and faculty. She currently holds an endowed faculty position under the Naddisy Family Foundation. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA.  She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology and is a member of ASCI (American Society of Clinical Investigation). She has authored or co-authored more than 110 original papers, and has maintained an interest in the study of immune mechanisms in allergy and asthma for more than 20 years. Her laboratory focuses on the study of immunological mechanisms involved in the cause, diagnosis, and therapy for allergy and asthma.  

Read Less
R r

Ashley Dombkowski

Co-Founder and CEO
Ashley Dombkowski, Ph.D. is Co-Founder and CEO of BEFORE Brands™, a consumer-focused product platform focused on health and wellness for parents and families. She co-founded the company in 2015 with Dr. Kari Nadeau, the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She has 20 years of experience as an operating executive, entrepreneur, and investor in fields spanning consumer health and life sciences. Her portfolio of innovative biotechnology, medical device, consumer health and HCIT companies has included 23andMe, Adolor, Alnara, BioVitrum, Epizyme, iPierian, Neosil, Nevro, Rigel, Tercica, and Twist. She previously served as a Managing Director with Bay City Capital, a $1.6B venture capital firm. Prior to that she served as Chief Business Officer and Vice President of Operations for 23andMe, where she oversaw the company’s finance and operations activities and had responsibility for the company’s long term business strategy. Before to joining 23andMe, she was a Managing Director with MPM Capital where she served as a member of the firm’s Investment Committee. Prior to this, she was an Equity Analyst for hedge fund Tiger Management L.L.C. and for institutional asset management firm Dresdner RCM Global Investors. Dr. Dombkowski holds a Ph.D. in Mathematics from Rice University and received her B.A. in Mathematics from Wellesley College. She has been widely quoted in publications ranging from Nature to The Wall Street Journal and she has appeared in media outlets including CNBC, SXSW, and TedMed. She was recognized as one of the 100 Most Influential Women in Business by the San Jose/Silicon Valley Business Journal in 2010. She is a member of the Board of Directors of USA Volleyball, the National Governing Body for all disciplines of Volleyball as recognized by the U.S. Olympic Committee, and serves as Chair of the Audit, Finance, and Budget committee.
Read Less

Kari Nadeau

Co-Founder and Inventor

Kari Nadeau, M.D., Ph.D. is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Her center’s vision is to find the causes and cures of allergies. Her center’s mission is to transform the lives of patients and families through innovative science and compassionate care.

After graduating from Haverford College (summa cum laude) with a degree in biology, Dr. Nadeau attended Harvard Medical School via the Medical Scientist Training Program (NIH), and received a PhD in Biological Chemistry and Molecular Pharmacology and an MD in 1995. She then performed an internship and residency in pediatrics at the Children’s Hospital Boston, Harvard Medical School. From 1998 to 2002, she worked in the field of biopharmaceuticals and led clinical research to obtain FDA approval for two biologics in the field of Autoimmunity and Oncology, respectively. From 2003-2006, Dr. Nadeau was a fellow in Asthma, Allergy and Immunology at the Stanford/UCSF program under Dr. Umetsu. During this time, she also did a postdoctoral fellowship in human immune tolerance mechanisms in asthma and allergy. In 2006, Dr. Nadeau was appointed to the Stanford University School of Medicine with appointments in Pediatrics and Otolaryngology. She enjoys mentoring students, post doctoral candidates, and faculty. She currently holds an endowed faculty position under the Naddisy Family Foundation. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA.  She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology and is a member of ASCI (American Society of Clinical Investigation). She has authored or co-authored more than 110 original papers, and has maintained an interest in the study of immune mechanisms in allergy and asthma for more than 20 years. Her laboratory focuses on the study of immunological mechanisms involved in the cause, diagnosis, and therapy for allergy and asthma.  

Read Less

Executive Team

Chris Cornyn

Chief Innovation Officer
Chris is the Chief Innovation Officer of BEFORE Brands™ and is responsible for all Product and Brand Development for the company. Chris was formerly the Chief Innovation Officer for Revolution Foods, a company that creates delicious foods to improve the health and wellbeing of students and families across the United States. Chris and his team led new product innovations, new services, new products, and new brands to further the growth of the Revolution mission. Chris was the founder of DINE, The Food & Drink Agency which was created to help food entrepreneurs launch and promote disruptive new food brands. In 2011, Chris sold DINE to Mattson, the largest independent food and beverage innovation company in the country. During his tenure, Chris and his team launched over 20 new food brands with 60+ SKUs. Chris began his branding and marketing career working with Klondike Ice Cream Bars, Betty Crocker and Yoplait Frozen Yogurt. Chris is a frequent speaker and featured contributor to business and food publications. He co-starred as one of the celebrity mentors on the Lifetime TV show "Supermarket Superstar."
Read Less

Marc Chapman

Chief Operating Officer
Marc is the Chief Operating Officer for BEFORE Brands™ where he leads the company’s e-Commerce operations, Manufacturing, Supply Chain, IT and Support functions.  Marc is a seasoned technology executive with a broad range of experiences with businesses at all levels of maturity and size. His background includes enterprise (Kodak, Intel, Hewlett Packard) and early stage companies (Snapfish, Minted, Symphony Commerce) spanning Direct to Consumer (D2C) and Business to Business (B2B) economic models. He was a founding employee and member of the executive management team responsible for building Snapfish.com and guiding it from conception to purchase by HP in 2005 for $300M.  Most recently, he was Chief Operating Officer of Symphony Commerce,  a SaaS technology platform providing commerce and fulfillment software to small and medium sized businesses.  Prior to that, he was Chief Operating Officer for Minted.com, an online marketplace comprised of independent artists who sell their designs on printed and digital products.  Marc has also held finance and strategy roles with both Eastman Kodak Company and Intel Corporation.
Read Less

Wendy Sue Swanson, MD, MBE, FAAP

Chief Medical Officer
Pediatrician and author Dr. Wendy Sue Swanson is a prominent advocate of evidence-based medicine and prevention. She has been working to revolutionize health communications by using social and digital media to bridge the gap between parents and doctors. Dr. Swanson founded Digital Health at Seattle Children's in 2013, leading a team in innovation by testing and creating new digital tools to leverage the wisdom of patients, families and providers. A graduate in Psychology from Kenyon College, Dr. Swanson earned an MD and MBE (Master's in Bioethics) at the University of Pennsylvania School Of Medicine and completed her residency at Seattle Children's Hospital. As Chief Medical Officer for Before Brands, Dr. Swanson is leading efforts to foster conversations around the importance of early and consistent inclusion of potential allergens in the diet.

She is an official spokesperson for The American Academy of Pediatrics and sits on their Council on Communications and Media, is on the Board of Advisors for Parents Magazine, and is a platinum fellow on the board for the Mayo Clinic Center for Social Media and is a practicing pediatrician with The Everett Clinic. Her first book,Mama Doc Medicine: Finding Calm and Confidence in Parenting, Child Health, and Work-Life Balance was published by the American Academy of Pediatrics in March, 2014 and is a Gold Award Recipient of the Mom's Choice Awards."
Read Less

Ben Thomander

VP Finance
Ben is the VP of Finance for BEFORE Brands where he leads the company's finance, accounting, and treasury activities.  Previously Ben served as Controller for 23andMe, Inc., the leading personal genetics company, and as Treasurer of the 23andMe Research Institute. Prior to 23andMe, Ben worked at Connor Group in its Technical Accounting and IPO Services practice where he assisted technology companies with complex revenue recognition issues and IPO filings. Prior to Connor Group, Ben worked as a Manager at PricewaterhouseCoopers in San Jose, in the Life Science and Venture Capital Group, providing audit and assurance services to various public and privately held companies in the pharmaceutical, biotechnology, and medical device spaces. Ben holds a Bachelor of Science degree in Accounting from Brigham Young University and is a Certified Public Accountant.
Read Less

Chris Cornyn

Chief Innovation Officer
Chris is the Chief Innovation Officer of BEFORE Brands™ and is responsible for all Product and Brand Development for the company. Chris was formerly the Chief Innovation Officer for Revolution Foods, a company that creates delicious foods to improve the health and wellbeing of students and families across the United States. Chris and his team led new product innovations, new services, new products, and new brands to further the growth of the Revolution mission. Chris was the founder of DINE, The Food & Drink Agency which was created to help food entrepreneurs launch and promote disruptive new food brands. In 2011, Chris sold DINE to Mattson, the largest independent food and beverage innovation company in the country. During his tenure, Chris and his team launched over 20 new food brands with 60+ SKUs. Chris began his branding and marketing career working with Klondike Ice Cream Bars, Betty Crocker and Yoplait Frozen Yogurt. Chris is a frequent speaker and featured contributor to business and food publications. He co-starred as one of the celebrity mentors on the Lifetime TV show "Supermarket Superstar."
Read Less

Marc Chapman

Chief Operating Officer
Marc is the Chief Operating Officer for BEFORE Brands™ where he leads the company’s e-Commerce operations, Manufacturing, Supply Chain, IT and Support functions.  Marc is a seasoned technology executive with a broad range of experiences with businesses at all levels of maturity and size. His background includes enterprise (Kodak, Intel, Hewlett Packard) and early stage companies (Snapfish, Minted, Symphony Commerce) spanning Direct to Consumer (D2C) and Business to Business (B2B) economic models. He was a founding employee and member of the executive management team responsible for building Snapfish.com and guiding it from conception to purchase by HP in 2005 for $300M.  Most recently, he was Chief Operating Officer of Symphony Commerce,  a SaaS technology platform providing commerce and fulfillment software to small and medium sized businesses.  Prior to that, he was Chief Operating Officer for Minted.com, an online marketplace comprised of independent artists who sell their designs on printed and digital products.  Marc has also held finance and strategy roles with both Eastman Kodak Company and Intel Corporation.
Read Less

Wendy Sue Swanson, MD, MBE, FAAP

Chief Medical Officer
Pediatrician and author Dr. Wendy Sue Swanson is a prominent advocate of evidence-based medicine and prevention. She has been working to revolutionize health communications by using social and digital media to bridge the gap between parents and doctors. Dr. Swanson founded Digital Health at Seattle Children's in 2013, leading a team in innovation by testing and creating new digital tools to leverage the wisdom of patients, families and providers. A graduate in Psychology from Kenyon College, Dr. Swanson earned an MD and MBE (Master's in Bioethics) at the University of Pennsylvania School Of Medicine and completed her residency at Seattle Children's Hospital. As Chief Medical Officer for Before Brands, Dr. Swanson is leading efforts to foster conversations around the importance of early and consistent inclusion of potential allergens in the diet.

She is an official spokesperson for The American Academy of Pediatrics and sits on their Council on Communications and Media, is on the Board of Advisors for Parents Magazine, and is a platinum fellow on the board for the Mayo Clinic Center for Social Media and is a practicing pediatrician with The Everett Clinic. Her first book,Mama Doc Medicine: Finding Calm and Confidence in Parenting, Child Health, and Work-Life Balance was published by the American Academy of Pediatrics in March, 2014 and is a Gold Award Recipient of the Mom's Choice Awards."
Read Less

Ben Thomander

VP Finance
Ben is the VP of Finance for BEFORE Brands where he leads the company's finance, accounting, and treasury activities.  Previously Ben served as Controller for 23andMe, Inc., the leading personal genetics company, and as Treasurer of the 23andMe Research Institute. Prior to 23andMe, Ben worked at Connor Group in its Technical Accounting and IPO Services practice where he assisted technology companies with complex revenue recognition issues and IPO filings. Prior to Connor Group, Ben worked as a Manager at PricewaterhouseCoopers in San Jose, in the Life Science and Venture Capital Group, providing audit and assurance services to various public and privately held companies in the pharmaceutical, biotechnology, and medical device spaces. Ben holds a Bachelor of Science degree in Accounting from Brigham Young University and is a Certified Public Accountant.
Read Less
R r

Chris Cornyn

Chief Innovation Officer
Chris is the Chief Innovation Officer of BEFORE Brands™ and is responsible for all Product and Brand Development for the company. Chris was formerly the Chief Innovation Officer for Revolution Foods, a company that creates delicious foods to improve the health and wellbeing of students and families across the United States. Chris and his team led new product innovations, new services, new products, and new brands to further the growth of the Revolution mission. Chris was the founder of DINE, The Food & Drink Agency which was created to help food entrepreneurs launch and promote disruptive new food brands. In 2011, Chris sold DINE to Mattson, the largest independent food and beverage innovation company in the country. During his tenure, Chris and his team launched over 20 new food brands with 60+ SKUs. Chris began his branding and marketing career working with Klondike Ice Cream Bars, Betty Crocker and Yoplait Frozen Yogurt. Chris is a frequent speaker and featured contributor to business and food publications. He co-starred as one of the celebrity mentors on the Lifetime TV show "Supermarket Superstar."
Read Less

Marc Chapman

Chief Operating Officer
Marc is the Chief Operating Officer for BEFORE Brands™ where he leads the company’s e-Commerce operations, Manufacturing, Supply Chain, IT and Support functions.  Marc is a seasoned technology executive with a broad range of experiences with businesses at all levels of maturity and size. His background includes enterprise (Kodak, Intel, Hewlett Packard) and early stage companies (Snapfish, Minted, Symphony Commerce) spanning Direct to Consumer (D2C) and Business to Business (B2B) economic models. He was a founding employee and member of the executive management team responsible for building Snapfish.com and guiding it from conception to purchase by HP in 2005 for $300M.  Most recently, he was Chief Operating Officer of Symphony Commerce,  a SaaS technology platform providing commerce and fulfillment software to small and medium sized businesses.  Prior to that, he was Chief Operating Officer for Minted.com, an online marketplace comprised of independent artists who sell their designs on printed and digital products.  Marc has also held finance and strategy roles with both Eastman Kodak Company and Intel Corporation.
Read Less

Wendy Sue Swanson, MD, MBE, FAAP

Chief Medical Officer
Pediatrician and author Dr. Wendy Sue Swanson is a prominent advocate of evidence-based medicine and prevention. She has been working to revolutionize health communications by using social and digital media to bridge the gap between parents and doctors. Dr. Swanson founded Digital Health at Seattle Children's in 2013, leading a team in innovation by testing and creating new digital tools to leverage the wisdom of patients, families and providers. A graduate in Psychology from Kenyon College, Dr. Swanson earned an MD and MBE (Master's in Bioethics) at the University of Pennsylvania School Of Medicine and completed her residency at Seattle Children's Hospital. As Chief Medical Officer for Before Brands, Dr. Swanson is leading efforts to foster conversations around the importance of early and consistent inclusion of potential allergens in the diet.

She is an official spokesperson for The American Academy of Pediatrics and sits on their Council on Communications and Media, is on the Board of Advisors for Parents Magazine, and is a platinum fellow on the board for the Mayo Clinic Center for Social Media and is a practicing pediatrician with The Everett Clinic. Her first book,Mama Doc Medicine: Finding Calm and Confidence in Parenting, Child Health, and Work-Life Balance was published by the American Academy of Pediatrics in March, 2014 and is a Gold Award Recipient of the Mom's Choice Awards."
Read Less

Ben Thomander

VP Finance
Ben is the VP of Finance for BEFORE Brands where he leads the company's finance, accounting, and treasury activities.  Previously Ben served as Controller for 23andMe, Inc., the leading personal genetics company, and as Treasurer of the 23andMe Research Institute. Prior to 23andMe, Ben worked at Connor Group in its Technical Accounting and IPO Services practice where he assisted technology companies with complex revenue recognition issues and IPO filings. Prior to Connor Group, Ben worked as a Manager at PricewaterhouseCoopers in San Jose, in the Life Science and Venture Capital Group, providing audit and assurance services to various public and privately held companies in the pharmaceutical, biotechnology, and medical device spaces. Ben holds a Bachelor of Science degree in Accounting from Brigham Young University and is a Certified Public Accountant.
Read Less

Board

Christopher A. Viehbacher

Board Member

Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation. He is also a member of the Board of Pure Tech Health plc and is the Chairman of Vedanta, a Pure Tech portfolio company. He is a member of the Board of Trustees of Northeastern University. Chris is the former CEO and Member of the Board of Directors of Sanofi, a Fortune 50 Biopharmaceutical company based in Paris. He was also the Chairman of the Board of Genzyme in Boston. Prior to joining Sanofi, Chris spent 20 years with GlaxoSmithKline in Germany, Canada, France and, latterly, the US as President of GSK North America. He was a Member of the Board of Directors of GSK plc in London and Co-President of GSK’s Portfolio Management Board. Chris began his career with Price Waterhouse after graduating with a degree in Commerce at Queen/s University in Canada. Chris has been a strong advocate for the healthcare industry. Current and past advocacy roles include:

Former Co-chair with Bill Gates, the CEO Roundtable on Neglected Diseases

Past-Chairman of the CEO Roundtable on Cancer. Chairman of the Board of the Pharmaceutical Research and Manufacturers of America in Washington

President of the European Federation of Pharmaceutical Industries and Associations in Brussels.

Chair of the Health Governors at World Economic Forum and Co-chair of a WEF initiative to create a Global Charter for Healthy Living.

Member of the International Business Council.

Chris has in the past served on various advisory groups at MIT, Duke University and Queen’s University at Kingston, Ontario.

Chris has received the Pasteur Foundation Award for outstanding commitment to safeguarding and improving health worldwide. He has also received France’s highest civilian honor, the Legion d’Honneur.

Read Less

Greg Horn

Board Member
Greg Horn is a leading innovator in health and nutrition business, with two decades of experience in developing and managing companies associated with personal health, nutrition and environmental sustainability. Greg is CEO of Specialty Nutrition Group, Inc. a development firm focused on commercializing nutrition innovation.  He has co-founded and managed several branded nutrition and healthy living companies, including Celsius®, Brand New Brands, Attune Foods, Pronutria Biosciences (now Axcella Health), WikiFoods and Nutrition Capital Network. He is former CEO of both Garden of Life, currently the top nutrition brand in the natural channel and General Nutrition Centers (GNC), the world’s largest specialty retailer of nutrition products, which added $100 million per year to profitable revenue for eleven years in a row during his tenure in management. Greg is the best-selling author of Living Green (2005)Living Well (2016), the co-author or The Meaning of Light and co-founder of Eco Shoppe. Greg holds an MBA from UCLA and a BA (summa cum laude, phi beta kappa) from the University of Redlands.
Read Less

George Montgomery

Board Member
George Montgomery is a Partner with Gurnet Point Capital and has more than 25 years of experience in healthcare entrepreneurship, investment banking, and venture investing. He is an experienced operating executive, having served as CFO for Coherus BioSciences where he oversaw all finance and business development activities for the company. He previously served as a Managing Director at Sagent Advisors, LLC. and as a Managing Director at Montgomery& Co., LLC where he led the firm’s healthcare effort and helped open their SanFrancisco office. During his tenure at Montgomery & Co, he served on the firm’s Board of Directors and was a member of the executive committee. Prior to Montgomery & Co., he was a Managing Director at JP Morgan H&Q where he led the firm’s healthcare efforts on the West Coast. He has also been a Managing Director at Cowen & Company and started his career at Credit Suisse First Boston in 1983. George received his MBA from the Wharton School at the University of Pennsylvania and his BA fromYale College.
Read Less

Christopher A. Viehbacher

Board Member

Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation. He is also a member of the Board of Pure Tech Health plc and is the Chairman of Vedanta, a Pure Tech portfolio company. He is a member of the Board of Trustees of Northeastern University. Chris is the former CEO and Member of the Board of Directors of Sanofi, a Fortune 50 Biopharmaceutical company based in Paris. He was also the Chairman of the Board of Genzyme in Boston. Prior to joining Sanofi, Chris spent 20 years with GlaxoSmithKline in Germany, Canada, France and, latterly, the US as President of GSK North America. He was a Member of the Board of Directors of GSK plc in London and Co-President of GSK’s Portfolio Management Board. Chris began his career with Price Waterhouse after graduating with a degree in Commerce at Queen/s University in Canada. Chris has been a strong advocate for the healthcare industry. Current and past advocacy roles include:

Former Co-chair with Bill Gates, the CEO Roundtable on Neglected Diseases

Past-Chairman of the CEO Roundtable on Cancer. Chairman of the Board of the Pharmaceutical Research and Manufacturers of America in Washington

President of the European Federation of Pharmaceutical Industries and Associations in Brussels.

Chair of the Health Governors at World Economic Forum and Co-chair of a WEF initiative to create a Global Charter for Healthy Living.

Member of the International Business Council.

Chris has in the past served on various advisory groups at MIT, Duke University and Queen’s University at Kingston, Ontario.

Chris has received the Pasteur Foundation Award for outstanding commitment to safeguarding and improving health worldwide. He has also received France’s highest civilian honor, the Legion d’Honneur.

Read Less

Greg Horn

Board Member
Greg Horn is a leading innovator in health and nutrition business, with two decades of experience in developing and managing companies associated with personal health, nutrition and environmental sustainability. Greg is CEO of Specialty Nutrition Group, Inc. a development firm focused on commercializing nutrition innovation.  He has co-founded and managed several branded nutrition and healthy living companies, including Celsius®, Brand New Brands, Attune Foods, Pronutria Biosciences (now Axcella Health), WikiFoods and Nutrition Capital Network. He is former CEO of both Garden of Life, currently the top nutrition brand in the natural channel and General Nutrition Centers (GNC), the world’s largest specialty retailer of nutrition products, which added $100 million per year to profitable revenue for eleven years in a row during his tenure in management. Greg is the best-selling author of Living Green (2005)Living Well (2016), the co-author or The Meaning of Light and co-founder of Eco Shoppe. Greg holds an MBA from UCLA and a BA (summa cum laude, phi beta kappa) from the University of Redlands.
Read Less

George Montgomery

Board Member
George Montgomery is a Partner with Gurnet Point Capital and has more than 25 years of experience in healthcare entrepreneurship, investment banking, and venture investing. He is an experienced operating executive, having served as CFO for Coherus BioSciences where he oversaw all finance and business development activities for the company. He previously served as a Managing Director at Sagent Advisors, LLC. and as a Managing Director at Montgomery& Co., LLC where he led the firm’s healthcare effort and helped open their SanFrancisco office. During his tenure at Montgomery & Co, he served on the firm’s Board of Directors and was a member of the executive committee. Prior to Montgomery & Co., he was a Managing Director at JP Morgan H&Q where he led the firm’s healthcare efforts on the West Coast. He has also been a Managing Director at Cowen & Company and started his career at Credit Suisse First Boston in 1983. George received his MBA from the Wharton School at the University of Pennsylvania and his BA fromYale College.
Read Less
R r

Christopher A. Viehbacher

Board Member

Chris Viehbacher is the Managing Partner of Gurnet Point Capital. Gurnet Point is a Boston based investment fund associated with the Bertarelli family and has a $ 2 billion capital allocation. He is also a member of the Board of Pure Tech Health plc and is the Chairman of Vedanta, a Pure Tech portfolio company. He is a member of the Board of Trustees of Northeastern University. Chris is the former CEO and Member of the Board of Directors of Sanofi, a Fortune 50 Biopharmaceutical company based in Paris. He was also the Chairman of the Board of Genzyme in Boston. Prior to joining Sanofi, Chris spent 20 years with GlaxoSmithKline in Germany, Canada, France and, latterly, the US as President of GSK North America. He was a Member of the Board of Directors of GSK plc in London and Co-President of GSK’s Portfolio Management Board. Chris began his career with Price Waterhouse after graduating with a degree in Commerce at Queen/s University in Canada. Chris has been a strong advocate for the healthcare industry. Current and past advocacy roles include:

Former Co-chair with Bill Gates, the CEO Roundtable on Neglected Diseases

Past-Chairman of the CEO Roundtable on Cancer. Chairman of the Board of the Pharmaceutical Research and Manufacturers of America in Washington

President of the European Federation of Pharmaceutical Industries and Associations in Brussels.

Chair of the Health Governors at World Economic Forum and Co-chair of a WEF initiative to create a Global Charter for Healthy Living.

Member of the International Business Council.

Chris has in the past served on various advisory groups at MIT, Duke University and Queen’s University at Kingston, Ontario.

Chris has received the Pasteur Foundation Award for outstanding commitment to safeguarding and improving health worldwide. He has also received France’s highest civilian honor, the Legion d’Honneur.

Read Less

Greg Horn

Board Member
Greg Horn is a leading innovator in health and nutrition business, with two decades of experience in developing and managing companies associated with personal health, nutrition and environmental sustainability. Greg is CEO of Specialty Nutrition Group, Inc. a development firm focused on commercializing nutrition innovation.  He has co-founded and managed several branded nutrition and healthy living companies, including Celsius®, Brand New Brands, Attune Foods, Pronutria Biosciences (now Axcella Health), WikiFoods and Nutrition Capital Network. He is former CEO of both Garden of Life, currently the top nutrition brand in the natural channel and General Nutrition Centers (GNC), the world’s largest specialty retailer of nutrition products, which added $100 million per year to profitable revenue for eleven years in a row during his tenure in management. Greg is the best-selling author of Living Green (2005)Living Well (2016), the co-author or The Meaning of Light and co-founder of Eco Shoppe. Greg holds an MBA from UCLA and a BA (summa cum laude, phi beta kappa) from the University of Redlands.
Read Less

George Montgomery

Board Member
George Montgomery is a Partner with Gurnet Point Capital and has more than 25 years of experience in healthcare entrepreneurship, investment banking, and venture investing. He is an experienced operating executive, having served as CFO for Coherus BioSciences where he oversaw all finance and business development activities for the company. He previously served as a Managing Director at Sagent Advisors, LLC. and as a Managing Director at Montgomery& Co., LLC where he led the firm’s healthcare effort and helped open their SanFrancisco office. During his tenure at Montgomery & Co, he served on the firm’s Board of Directors and was a member of the executive committee. Prior to Montgomery & Co., he was a Managing Director at JP Morgan H&Q where he led the firm’s healthcare efforts on the West Coast. He has also been a Managing Director at Cowen & Company and started his career at Credit Suisse First Boston in 1983. George received his MBA from the Wharton School at the University of Pennsylvania and his BA fromYale College.
Read Less

Advisors

Dr. Kari Nadeau, M.D.,Ph.D.

Dr. Kari Nadeau is one of the nation’s foremost experts in adult and pediatric allergy and asthma. She is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Section Chief of Allergy and Asthma at the Stanford School of Medicine, and an endowed professor under the Naddisy Family Foundation. Dr. Nadeau received her MD and PhD from Harvard Medical School, completed a residency in pediatrics at Boston Children’s Hospital and a clinical fellowship in asthma and immunology at Stanford. After completing her residency, she spent 5 years in the biopharmaceutical industry, where she was instrumental in obtaining FDA approval for two biologics in the #elds of autoimmunity and oncology, before starting her fellowship at Stanford. Dr. Nadeau has received honors and awards from the American Academy of Allergy, Asthma & Immunology; the American Lung Association; the Clinical Immunological Society; Food Allergy Research & Education (FARE); and the NIH. She has also been recognized with the U.S. Environmental Protection Agency’s STAR Grant Award. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA. She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology as well as a member of ASCI (American Society of Clinical Investigation). She has authored or co-authored more than 100 original papers. Her research focuses on understanding the factors responsible for the increased prevalence of allergies and asthma in the population, improving diagnostics, and understanding the immunological mechanisms underlying these diseases. She was the first to successfully desensitize individuals to more than one allergy at a time using multi-allergen oral immunotherapy. She continues to push forward with innovative clinical research using novel antibodies, peptide vaccines, and nanoparticles in order to provide safe and effective therapeutic options for those with allergies and asthma.
Read Less

Katrina (Katie) J. Allen, MBBS, Ph.D.

Katrina (Katie) J. Allen, MBBS, Ph.D., is a Paediatric Allergist and Gastroenterologist practising in the field of Food Allergy at the Royal Children’s Hospital, Melbourne, Australia. Professor Allen is also Theme Director of Population Health at the Murdoch Childrens Research Institute, Professor of Paediatrics at the University of Melbourne, and Professor of Food Allergy at the University of Manchester, UK. She is an inaugural fellow of the Australian Academy of Health and Medical Science, and Director of the National Health and Medical Research Council (NHMRC)-funded Australian Centre of Food & Allergy Research which aims to translate research findings into clinical practice and public health policy to ensure the best outcomes for children regarding food allergy. Professor Allen is on five NHMRC funded studies which all seek to answer questions about population health and evolution of the new allergy epidemic including gene-environment, immunologic and epigenetic associations with food allergy. One of such studies, the HealthNuts study, includes 5,300 infants followed over the first 10 years of life. In 2010, Professor Allen’s research was recognised in the NHMRC ’10 of the Best’ nationally and she has published extensively with more than 230 peer-reviewed papers and book chapters. She also sits on a variety of committees for the European Academy of Allergy and Clinical Immunology (including the food allergy section Board), American Academy of Allergy, Asthma and Immunology, World Allergy Organisation and the Australasian Society of Clinical Immunology and Allergy Paediatric Committee.
Read Less

Eugene Bauer, M.D.

Eugene Bauer, M.D. is a co-founder of Dermira, our Chief Medical Officer and a member of our board of directors. Prior to founding Dermira, he served as a member of Peplin’s board of directors, and its President and Chief Medical Officer, until its acquisition by LEO Pharma. He was also the Chief Executive Officer of Neosil Inc., and a co-founder and member of the board of directors at Connetics. Before initiating his career in industry, he served as the Dean of the Stanford University School of Medicine and as Chair of the Department of Dermatology at the Stanford University School of Medicine. He is a Lucy Becker Professor, Emeritus, in the School of Medicine at Stanford University, a position he has held since 2002. Gene has served on the boards of directors of a number of public and private companies. He is currently a member of the boards of directors of Aevi Genomic Medicine, Inc. (formerly Medgenics, Inc.), First Wave Technologies, Inc., Cerecor, Inc. and Kadmon Corporation. He previously served as a member of the boards of directors of Dr. Tattoff, Inc., Protalex, Inc., Vyteris, Inc., Peplin, PetDRx, Inc., Arbor Vita Corp., Patient Safety Technologies, Inc., MediSync Bioservices and Modigene Inc. (renamed PROLOR Biotech, Inc.).  Gene was a U.S. National Institutes of Health (NIH)-funded investigator for 25 years and has served on review groups for the NIH. He has been elected to several societies, including the National Academy of Medicine of the United States, and currently serves as a director of the American Dermatological Association, Inc. Gene received a B.S. in medicine and an M.D. from Northwestern University.
Read Less

Ruchi Gupta, M.D., M.P.H.

Ruchi Gupta, M.D., M.P.H. has more than 15 years of experience as a board-certified pediatrician and health researcher. She completed her undergraduate and medical education at the University of Louisville. She completed her medical residency at Children's Hospital & Regional Medical Center, University of Washington in Seattle, WA and then a pediatric health services research fellowship at Boston Children's Hospital and Harvard Medical School. Finally, she received her Masters of Public Health from the Harvard School of Public Health. She is nationally recognized for her groundbreaking research in the area of food allergy epidemiology; specifically her research on childhood food allergy prevalence. She has also significantly contributed to academic research surrounding economic costs, pediatric management of food allergy, ED visits and hospitalizations, quality of life and use of epinephrine in schools. Dr. Gupta has been a faculty member at Northwestern Medicine since 2004 and a clinical attending at the Ann & Robert H. Lurie Children's Hospital of Chicago where she is actively involved in clinical, epidemiological, and community research. Dr. Gupta leads the Food Allergy Outcomes Research Program and is a co­founder of the Food Allergy Research Consortium at Northwestern Medicine. She is also the author of the book The Food Allergy Experience. Dr. Gupta has over 60 publications and her work has been featured in major TV networks and print media.
Read Less

David L. Hill, M.D., FAAP

David L. Hill, MD, FAAP is the chair of the AAP Council on Communications and Media, a member of the AAP Children, Adolescents, and Media Leadership Working Group, and a scientific advisory board member of the Institute of Digital Media and Child Development as well as a board member of the North Carolina Pediatric Society. An adjunct assistant professor of pediatrics at UNC School of Medicine, he served as the 2014 Media Visiting Professor at Duke University.  Dr. Hill is also the author of Dad to Dad: Parenting Like a Pro (AAP Publishing, 2012) and has appeared in Hank Azaria’s Fatherhood online series for Disney, AOL, and mom.me. David has been a commentator for National Public Radio’s All Things Considered and a regular contributor to NPR member stations WUNC and WHQR as well as RadioMD’s “Healthy Children Radio.” He appears regularly on news stations WECT and WWAY and has been featured on CNN Headline News as well as in numerous online videos about pediatrics and parenting. A humorist and (very) occasional standup comedian, David maintained a regular humor blog (“Needles”) for Pediatric News from 2011 to 2014. Dr. Hill has worked as a medical content advisor for parents.com, Sharecare, Inc., and Pediacare Brands. Dr. Hill graduated from Rice University and attended medical school at the University of Texas Houston before completing a combined internal medicine/pediatrics residency at the UNC School of Medicine. He practices at Coastal Pediatric Associates in Wilmington, NC, where he lives with his wife, three children, and two step-children. For fun he runs and practices Tae Kwon Do with his children.
Read Less

Stephen Tilles, M.D.

Dr. Stephen Tilles is Clinical Professor at the University of Washington, Executive Director of ASTHMA Inc. Clinical Research Center, and Physician Partner at the Northwest Asthma and Allergy Center. He received his medical degree in 1990 from the University of California at San Diego after earning a BA at Harvard in 1982. He completed his internship and residency in Internal Medicine at the Oregon Health Sciences University in 1993, and his Allergy and Immunology fellowship at the National Jewish Center for Immunology and Respiratory Medicine in Denver in 1995. Before moving to Seattle in 2000, Dr. Tilles spent five years as Assistant Professor of Medicine and Pediatrics and Director of the Allergy and Asthma Clinic at the Oregon Health Sciences University. He is Board Certified in both Internal Medicine and Allergy and Immunology. Dr. Tilles splits his time between seeing patients in clinic and working at ASTHMA, Inc. Clinical Research Center, a non-profit clinical research center in Seattle. He has served as Principal Investigator for more than 140 clinical trials, evaluating treatments for asthma, rhinitis, urticaria, and food allergies.  Dr. Tilles has been selected on the lists of "Seattle's Best Doctors", "Seattle Super Doctors", "Washington's Best Doctors", and "America's Best Doctors". Dr. Tilles is a Past President of the Western Society of Asthma, Allergy and Immunology and the Oregon Society of Allergy, Asthma, and Immunology. He is currently President of the American College of Allergy, Asthma, and Immunology, and serves as a Board member of the American Board of Allergy and Immunology.
Read Less

Christopher Walsh

Christopher Walsh is a consulting professor to the Stanford University department of chemistry and an advisor to the Stanford ChEM-H institute. He was the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School from 1987-2013 when he took emeritus status. He has had extensive academic leadership experience, including Chairmanship of the MIT Chemistry Dept (1982-1987) and of the HMS Biological Chemistry & Molecular Pharmacology Dept (1987-1995) as well as serving as President and CEO of the Dana Farber Cancer Institute (1992-1995).  His research has focused on enzymes and enzyme inhibitors, with specialization on antibiotics and biosynthesis of other biologically and medicinally active natural products. He and his group authored 810 research papers, and five books: on Enzymatic Reaction Mechanisms (1979); Antibiotics: Origins, Actions, Resistance (2003); Posttranslational Modification of Proteins: Expanding Nature’s Inventory (2005); Antibiotics: Challenges, Mechanisms, Opportunities (2016). Natural Product Biosynthesis: Chemical Logic and Enzymatic Machinery (2017).  He is a member of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, the American Philosophical Society, and a co-recipient of the 2010 Welch Prize in Chemistry. At Harvard and MIT he taught biochemistry, chemical biology, and pharmacology to medical students and graduate students and organic chemistry to undergraduates.  He has been involved in a variety of venture-based biotechnology companies since 1981, including Genzyme, Immunogen, Leukosite, Millenium, Kosan, Vicuron, Epizyme. Currently he is on the board of directors of Ironwood, and Proteostasis,  and the non profits: California Institute for Biomedical Research and The Scripps Research Institute. He is a member of the scientific advisory groups at Hua, Abide, Cidara, and Flex Pharma, an advisor to Health Care Ventures and a limited investor in Health Care Ventures, MPM bioventures, Clarus, and the Longwood Venture Funds.  Chris is married to Diana Chapman Walsh who was president of Wellesley College from 1993-2007 and was the founding chair of the board of the Broad Institute of MIT and Harvard (2009-2014). Their daughter Allison Walsh Kurian is an Associate Professor of Medicine at Stanford and co-director of the High Risk Center for women with genetic predisposition to breast and ovarian cancer.
Read Less

Kimberly Yates

Community Advisor
Kimberly Yates is the Special Advisor to Kari Nadeau and Public Relations Officer at the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She has partnered with Kari for the past 8 years working tirelessly to make the creation of the Center possible as well as ensure the research, therapies and diagnostics are publicized and have the resources necessary to come to fruition. As the parent of the first Multi Allergen Oral Immunotherapy patient she also serves as an ambassador throughout the country for the Center and the treatments being done at Stanford. Her leadership bridges philanthropy, community outreach and support and communications to make the Center’s vision a reality.
Read Less

Melanie Staggs

Community Advisor
Melanie Staggs is active in numerous philanthropic and nonprofit organizations.  She has served and currently serves on the boards of various organizations, including the California Community Foundation, Baby2Baby and Harvard-Westlake School and runs an annual Thanksgiving food drive feeding over 10,000 through Big Sunday.  She is the founder of "Thursday Night at the Movies," raising funds for food allergy research and education and currently serves on the National Advisory Board for the Sean N. Parker Center for Allergy and Asthma Research at Stanford.  Melanie is an advisor for Goodshop, an online coupon and shopping company that donates a percentage of every purchase to the purchaser's designated cause. She has also co-authored the early reader book "The Startup Club" intended to introduce children at a young age to basic financial and entrepreneurial concepts. She previously worked in corporate strategic planning and brand management for the Walt Disney Company and in new business development for The Disney Stores.  She holds a BA in economics and an MA in international policy studies from Stanford University as well as an MBA from the Stanford Graduate School of Business. She is a lifetime resident of Southern California and the proud mother of three boys.
Read Less

Dr. Kari Nadeau, M.D.,Ph.D.

Dr. Kari Nadeau is one of the nation’s foremost experts in adult and pediatric allergy and asthma. She is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Section Chief of Allergy and Asthma at the Stanford School of Medicine, and an endowed professor under the Naddisy Family Foundation. Dr. Nadeau received her MD and PhD from Harvard Medical School, completed a residency in pediatrics at Boston Children’s Hospital and a clinical fellowship in asthma and immunology at Stanford. After completing her residency, she spent 5 years in the biopharmaceutical industry, where she was instrumental in obtaining FDA approval for two biologics in the #elds of autoimmunity and oncology, before starting her fellowship at Stanford. Dr. Nadeau has received honors and awards from the American Academy of Allergy, Asthma & Immunology; the American Lung Association; the Clinical Immunological Society; Food Allergy Research & Education (FARE); and the NIH. She has also been recognized with the U.S. Environmental Protection Agency’s STAR Grant Award. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA. She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology as well as a member of ASCI (American Society of Clinical Investigation). She has authored or co-authored more than 100 original papers. Her research focuses on understanding the factors responsible for the increased prevalence of allergies and asthma in the population, improving diagnostics, and understanding the immunological mechanisms underlying these diseases. She was the first to successfully desensitize individuals to more than one allergy at a time using multi-allergen oral immunotherapy. She continues to push forward with innovative clinical research using novel antibodies, peptide vaccines, and nanoparticles in order to provide safe and effective therapeutic options for those with allergies and asthma.
Read Less

Katrina (Katie) J. Allen, MBBS, Ph.D.

Katrina (Katie) J. Allen, MBBS, Ph.D., is a Paediatric Allergist and Gastroenterologist practising in the field of Food Allergy at the Royal Children’s Hospital, Melbourne, Australia. Professor Allen is also Theme Director of Population Health at the Murdoch Childrens Research Institute, Professor of Paediatrics at the University of Melbourne, and Professor of Food Allergy at the University of Manchester, UK. She is an inaugural fellow of the Australian Academy of Health and Medical Science, and Director of the National Health and Medical Research Council (NHMRC)-funded Australian Centre of Food & Allergy Research which aims to translate research findings into clinical practice and public health policy to ensure the best outcomes for children regarding food allergy. Professor Allen is on five NHMRC funded studies which all seek to answer questions about population health and evolution of the new allergy epidemic including gene-environment, immunologic and epigenetic associations with food allergy. One of such studies, the HealthNuts study, includes 5,300 infants followed over the first 10 years of life. In 2010, Professor Allen’s research was recognised in the NHMRC ’10 of the Best’ nationally and she has published extensively with more than 230 peer-reviewed papers and book chapters. She also sits on a variety of committees for the European Academy of Allergy and Clinical Immunology (including the food allergy section Board), American Academy of Allergy, Asthma and Immunology, World Allergy Organisation and the Australasian Society of Clinical Immunology and Allergy Paediatric Committee.
Read Less

Eugene Bauer, M.D.

Eugene Bauer, M.D. is a co-founder of Dermira, our Chief Medical Officer and a member of our board of directors. Prior to founding Dermira, he served as a member of Peplin’s board of directors, and its President and Chief Medical Officer, until its acquisition by LEO Pharma. He was also the Chief Executive Officer of Neosil Inc., and a co-founder and member of the board of directors at Connetics. Before initiating his career in industry, he served as the Dean of the Stanford University School of Medicine and as Chair of the Department of Dermatology at the Stanford University School of Medicine. He is a Lucy Becker Professor, Emeritus, in the School of Medicine at Stanford University, a position he has held since 2002. Gene has served on the boards of directors of a number of public and private companies. He is currently a member of the boards of directors of Aevi Genomic Medicine, Inc. (formerly Medgenics, Inc.), First Wave Technologies, Inc., Cerecor, Inc. and Kadmon Corporation. He previously served as a member of the boards of directors of Dr. Tattoff, Inc., Protalex, Inc., Vyteris, Inc., Peplin, PetDRx, Inc., Arbor Vita Corp., Patient Safety Technologies, Inc., MediSync Bioservices and Modigene Inc. (renamed PROLOR Biotech, Inc.).  Gene was a U.S. National Institutes of Health (NIH)-funded investigator for 25 years and has served on review groups for the NIH. He has been elected to several societies, including the National Academy of Medicine of the United States, and currently serves as a director of the American Dermatological Association, Inc. Gene received a B.S. in medicine and an M.D. from Northwestern University.
Read Less

Ruchi Gupta, M.D., M.P.H.

Ruchi Gupta, M.D., M.P.H. has more than 15 years of experience as a board-certified pediatrician and health researcher. She completed her undergraduate and medical education at the University of Louisville. She completed her medical residency at Children's Hospital & Regional Medical Center, University of Washington in Seattle, WA and then a pediatric health services research fellowship at Boston Children's Hospital and Harvard Medical School. Finally, she received her Masters of Public Health from the Harvard School of Public Health. She is nationally recognized for her groundbreaking research in the area of food allergy epidemiology; specifically her research on childhood food allergy prevalence. She has also significantly contributed to academic research surrounding economic costs, pediatric management of food allergy, ED visits and hospitalizations, quality of life and use of epinephrine in schools. Dr. Gupta has been a faculty member at Northwestern Medicine since 2004 and a clinical attending at the Ann & Robert H. Lurie Children's Hospital of Chicago where she is actively involved in clinical, epidemiological, and community research. Dr. Gupta leads the Food Allergy Outcomes Research Program and is a co­founder of the Food Allergy Research Consortium at Northwestern Medicine. She is also the author of the book The Food Allergy Experience. Dr. Gupta has over 60 publications and her work has been featured in major TV networks and print media.
Read Less

David L. Hill, M.D., FAAP

David L. Hill, MD, FAAP is the chair of the AAP Council on Communications and Media, a member of the AAP Children, Adolescents, and Media Leadership Working Group, and a scientific advisory board member of the Institute of Digital Media and Child Development as well as a board member of the North Carolina Pediatric Society. An adjunct assistant professor of pediatrics at UNC School of Medicine, he served as the 2014 Media Visiting Professor at Duke University.  Dr. Hill is also the author of Dad to Dad: Parenting Like a Pro (AAP Publishing, 2012) and has appeared in Hank Azaria’s Fatherhood online series for Disney, AOL, and mom.me. David has been a commentator for National Public Radio’s All Things Considered and a regular contributor to NPR member stations WUNC and WHQR as well as RadioMD’s “Healthy Children Radio.” He appears regularly on news stations WECT and WWAY and has been featured on CNN Headline News as well as in numerous online videos about pediatrics and parenting. A humorist and (very) occasional standup comedian, David maintained a regular humor blog (“Needles”) for Pediatric News from 2011 to 2014. Dr. Hill has worked as a medical content advisor for parents.com, Sharecare, Inc., and Pediacare Brands. Dr. Hill graduated from Rice University and attended medical school at the University of Texas Houston before completing a combined internal medicine/pediatrics residency at the UNC School of Medicine. He practices at Coastal Pediatric Associates in Wilmington, NC, where he lives with his wife, three children, and two step-children. For fun he runs and practices Tae Kwon Do with his children.
Read Less

Stephen Tilles, M.D.

Dr. Stephen Tilles is Clinical Professor at the University of Washington, Executive Director of ASTHMA Inc. Clinical Research Center, and Physician Partner at the Northwest Asthma and Allergy Center. He received his medical degree in 1990 from the University of California at San Diego after earning a BA at Harvard in 1982. He completed his internship and residency in Internal Medicine at the Oregon Health Sciences University in 1993, and his Allergy and Immunology fellowship at the National Jewish Center for Immunology and Respiratory Medicine in Denver in 1995. Before moving to Seattle in 2000, Dr. Tilles spent five years as Assistant Professor of Medicine and Pediatrics and Director of the Allergy and Asthma Clinic at the Oregon Health Sciences University. He is Board Certified in both Internal Medicine and Allergy and Immunology. Dr. Tilles splits his time between seeing patients in clinic and working at ASTHMA, Inc. Clinical Research Center, a non-profit clinical research center in Seattle. He has served as Principal Investigator for more than 140 clinical trials, evaluating treatments for asthma, rhinitis, urticaria, and food allergies.  Dr. Tilles has been selected on the lists of "Seattle's Best Doctors", "Seattle Super Doctors", "Washington's Best Doctors", and "America's Best Doctors". Dr. Tilles is a Past President of the Western Society of Asthma, Allergy and Immunology and the Oregon Society of Allergy, Asthma, and Immunology. He is currently President of the American College of Allergy, Asthma, and Immunology, and serves as a Board member of the American Board of Allergy and Immunology.
Read Less

Christopher Walsh

Christopher Walsh is a consulting professor to the Stanford University department of chemistry and an advisor to the Stanford ChEM-H institute. He was the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School from 1987-2013 when he took emeritus status. He has had extensive academic leadership experience, including Chairmanship of the MIT Chemistry Dept (1982-1987) and of the HMS Biological Chemistry & Molecular Pharmacology Dept (1987-1995) as well as serving as President and CEO of the Dana Farber Cancer Institute (1992-1995).  His research has focused on enzymes and enzyme inhibitors, with specialization on antibiotics and biosynthesis of other biologically and medicinally active natural products. He and his group authored 810 research papers, and five books: on Enzymatic Reaction Mechanisms (1979); Antibiotics: Origins, Actions, Resistance (2003); Posttranslational Modification of Proteins: Expanding Nature’s Inventory (2005); Antibiotics: Challenges, Mechanisms, Opportunities (2016). Natural Product Biosynthesis: Chemical Logic and Enzymatic Machinery (2017).  He is a member of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, the American Philosophical Society, and a co-recipient of the 2010 Welch Prize in Chemistry. At Harvard and MIT he taught biochemistry, chemical biology, and pharmacology to medical students and graduate students and organic chemistry to undergraduates.  He has been involved in a variety of venture-based biotechnology companies since 1981, including Genzyme, Immunogen, Leukosite, Millenium, Kosan, Vicuron, Epizyme. Currently he is on the board of directors of Ironwood, and Proteostasis,  and the non profits: California Institute for Biomedical Research and The Scripps Research Institute. He is a member of the scientific advisory groups at Hua, Abide, Cidara, and Flex Pharma, an advisor to Health Care Ventures and a limited investor in Health Care Ventures, MPM bioventures, Clarus, and the Longwood Venture Funds.  Chris is married to Diana Chapman Walsh who was president of Wellesley College from 1993-2007 and was the founding chair of the board of the Broad Institute of MIT and Harvard (2009-2014). Their daughter Allison Walsh Kurian is an Associate Professor of Medicine at Stanford and co-director of the High Risk Center for women with genetic predisposition to breast and ovarian cancer.
Read Less

Kimberly Yates

Community Advisor
Kimberly Yates is the Special Advisor to Kari Nadeau and Public Relations Officer at the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She has partnered with Kari for the past 8 years working tirelessly to make the creation of the Center possible as well as ensure the research, therapies and diagnostics are publicized and have the resources necessary to come to fruition. As the parent of the first Multi Allergen Oral Immunotherapy patient she also serves as an ambassador throughout the country for the Center and the treatments being done at Stanford. Her leadership bridges philanthropy, community outreach and support and communications to make the Center’s vision a reality.
Read Less

Melanie Staggs

Community Advisor
Melanie Staggs is active in numerous philanthropic and nonprofit organizations.  She has served and currently serves on the boards of various organizations, including the California Community Foundation, Baby2Baby and Harvard-Westlake School and runs an annual Thanksgiving food drive feeding over 10,000 through Big Sunday.  She is the founder of "Thursday Night at the Movies," raising funds for food allergy research and education and currently serves on the National Advisory Board for the Sean N. Parker Center for Allergy and Asthma Research at Stanford.  Melanie is an advisor for Goodshop, an online coupon and shopping company that donates a percentage of every purchase to the purchaser's designated cause. She has also co-authored the early reader book "The Startup Club" intended to introduce children at a young age to basic financial and entrepreneurial concepts. She previously worked in corporate strategic planning and brand management for the Walt Disney Company and in new business development for The Disney Stores.  She holds a BA in economics and an MA in international policy studies from Stanford University as well as an MBA from the Stanford Graduate School of Business. She is a lifetime resident of Southern California and the proud mother of three boys.
Read Less
R r

Dr. Kari Nadeau, M.D.,Ph.D.

Dr. Kari Nadeau is one of the nation’s foremost experts in adult and pediatric allergy and asthma. She is the Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Section Chief of Allergy and Asthma at the Stanford School of Medicine, and an endowed professor under the Naddisy Family Foundation. Dr. Nadeau received her MD and PhD from Harvard Medical School, completed a residency in pediatrics at Boston Children’s Hospital and a clinical fellowship in asthma and immunology at Stanford. After completing her residency, she spent 5 years in the biopharmaceutical industry, where she was instrumental in obtaining FDA approval for two biologics in the #elds of autoimmunity and oncology, before starting her fellowship at Stanford. Dr. Nadeau has received honors and awards from the American Academy of Allergy, Asthma & Immunology; the American Lung Association; the Clinical Immunological Society; Food Allergy Research & Education (FARE); and the NIH. She has also been recognized with the U.S. Environmental Protection Agency’s STAR Grant Award. Dr. Nadeau has served as a reviewer for NIH Study Sections, and a member of the American Lung Association Medical Board, CA. She serves on the Environmental Health Policy committee for the American Thoracic Society and is a Fellow in the American Academy of Allergy, Asthma and Immunology as well as a member of ASCI (American Society of Clinical Investigation). She has authored or co-authored more than 100 original papers. Her research focuses on understanding the factors responsible for the increased prevalence of allergies and asthma in the population, improving diagnostics, and understanding the immunological mechanisms underlying these diseases. She was the first to successfully desensitize individuals to more than one allergy at a time using multi-allergen oral immunotherapy. She continues to push forward with innovative clinical research using novel antibodies, peptide vaccines, and nanoparticles in order to provide safe and effective therapeutic options for those with allergies and asthma.
Read Less

Katrina (Katie) J. Allen, MBBS, Ph.D.

Katrina (Katie) J. Allen, MBBS, Ph.D., is a Paediatric Allergist and Gastroenterologist practising in the field of Food Allergy at the Royal Children’s Hospital, Melbourne, Australia. Professor Allen is also Theme Director of Population Health at the Murdoch Childrens Research Institute, Professor of Paediatrics at the University of Melbourne, and Professor of Food Allergy at the University of Manchester, UK. She is an inaugural fellow of the Australian Academy of Health and Medical Science, and Director of the National Health and Medical Research Council (NHMRC)-funded Australian Centre of Food & Allergy Research which aims to translate research findings into clinical practice and public health policy to ensure the best outcomes for children regarding food allergy. Professor Allen is on five NHMRC funded studies which all seek to answer questions about population health and evolution of the new allergy epidemic including gene-environment, immunologic and epigenetic associations with food allergy. One of such studies, the HealthNuts study, includes 5,300 infants followed over the first 10 years of life. In 2010, Professor Allen’s research was recognised in the NHMRC ’10 of the Best’ nationally and she has published extensively with more than 230 peer-reviewed papers and book chapters. She also sits on a variety of committees for the European Academy of Allergy and Clinical Immunology (including the food allergy section Board), American Academy of Allergy, Asthma and Immunology, World Allergy Organisation and the Australasian Society of Clinical Immunology and Allergy Paediatric Committee.
Read Less

Eugene Bauer, M.D.

Eugene Bauer, M.D. is a co-founder of Dermira, our Chief Medical Officer and a member of our board of directors. Prior to founding Dermira, he served as a member of Peplin’s board of directors, and its President and Chief Medical Officer, until its acquisition by LEO Pharma. He was also the Chief Executive Officer of Neosil Inc., and a co-founder and member of the board of directors at Connetics. Before initiating his career in industry, he served as the Dean of the Stanford University School of Medicine and as Chair of the Department of Dermatology at the Stanford University School of Medicine. He is a Lucy Becker Professor, Emeritus, in the School of Medicine at Stanford University, a position he has held since 2002. Gene has served on the boards of directors of a number of public and private companies. He is currently a member of the boards of directors of Aevi Genomic Medicine, Inc. (formerly Medgenics, Inc.), First Wave Technologies, Inc., Cerecor, Inc. and Kadmon Corporation. He previously served as a member of the boards of directors of Dr. Tattoff, Inc., Protalex, Inc., Vyteris, Inc., Peplin, PetDRx, Inc., Arbor Vita Corp., Patient Safety Technologies, Inc., MediSync Bioservices and Modigene Inc. (renamed PROLOR Biotech, Inc.).  Gene was a U.S. National Institutes of Health (NIH)-funded investigator for 25 years and has served on review groups for the NIH. He has been elected to several societies, including the National Academy of Medicine of the United States, and currently serves as a director of the American Dermatological Association, Inc. Gene received a B.S. in medicine and an M.D. from Northwestern University.
Read Less

Ruchi Gupta, M.D., M.P.H.

Ruchi Gupta, M.D., M.P.H. has more than 15 years of experience as a board-certified pediatrician and health researcher. She completed her undergraduate and medical education at the University of Louisville. She completed her medical residency at Children's Hospital & Regional Medical Center, University of Washington in Seattle, WA and then a pediatric health services research fellowship at Boston Children's Hospital and Harvard Medical School. Finally, she received her Masters of Public Health from the Harvard School of Public Health. She is nationally recognized for her groundbreaking research in the area of food allergy epidemiology; specifically her research on childhood food allergy prevalence. She has also significantly contributed to academic research surrounding economic costs, pediatric management of food allergy, ED visits and hospitalizations, quality of life and use of epinephrine in schools. Dr. Gupta has been a faculty member at Northwestern Medicine since 2004 and a clinical attending at the Ann & Robert H. Lurie Children's Hospital of Chicago where she is actively involved in clinical, epidemiological, and community research. Dr. Gupta leads the Food Allergy Outcomes Research Program and is a co­founder of the Food Allergy Research Consortium at Northwestern Medicine. She is also the author of the book The Food Allergy Experience. Dr. Gupta has over 60 publications and her work has been featured in major TV networks and print media.
Read Less

David L. Hill, M.D., FAAP

David L. Hill, MD, FAAP is the chair of the AAP Council on Communications and Media, a member of the AAP Children, Adolescents, and Media Leadership Working Group, and a scientific advisory board member of the Institute of Digital Media and Child Development as well as a board member of the North Carolina Pediatric Society. An adjunct assistant professor of pediatrics at UNC School of Medicine, he served as the 2014 Media Visiting Professor at Duke University.  Dr. Hill is also the author of Dad to Dad: Parenting Like a Pro (AAP Publishing, 2012) and has appeared in Hank Azaria’s Fatherhood online series for Disney, AOL, and mom.me. David has been a commentator for National Public Radio’s All Things Considered and a regular contributor to NPR member stations WUNC and WHQR as well as RadioMD’s “Healthy Children Radio.” He appears regularly on news stations WECT and WWAY and has been featured on CNN Headline News as well as in numerous online videos about pediatrics and parenting. A humorist and (very) occasional standup comedian, David maintained a regular humor blog (“Needles”) for Pediatric News from 2011 to 2014. Dr. Hill has worked as a medical content advisor for parents.com, Sharecare, Inc., and Pediacare Brands. Dr. Hill graduated from Rice University and attended medical school at the University of Texas Houston before completing a combined internal medicine/pediatrics residency at the UNC School of Medicine. He practices at Coastal Pediatric Associates in Wilmington, NC, where he lives with his wife, three children, and two step-children. For fun he runs and practices Tae Kwon Do with his children.
Read Less

Stephen Tilles, M.D.

Dr. Stephen Tilles is Clinical Professor at the University of Washington, Executive Director of ASTHMA Inc. Clinical Research Center, and Physician Partner at the Northwest Asthma and Allergy Center. He received his medical degree in 1990 from the University of California at San Diego after earning a BA at Harvard in 1982. He completed his internship and residency in Internal Medicine at the Oregon Health Sciences University in 1993, and his Allergy and Immunology fellowship at the National Jewish Center for Immunology and Respiratory Medicine in Denver in 1995. Before moving to Seattle in 2000, Dr. Tilles spent five years as Assistant Professor of Medicine and Pediatrics and Director of the Allergy and Asthma Clinic at the Oregon Health Sciences University. He is Board Certified in both Internal Medicine and Allergy and Immunology. Dr. Tilles splits his time between seeing patients in clinic and working at ASTHMA, Inc. Clinical Research Center, a non-profit clinical research center in Seattle. He has served as Principal Investigator for more than 140 clinical trials, evaluating treatments for asthma, rhinitis, urticaria, and food allergies.  Dr. Tilles has been selected on the lists of "Seattle's Best Doctors", "Seattle Super Doctors", "Washington's Best Doctors", and "America's Best Doctors". Dr. Tilles is a Past President of the Western Society of Asthma, Allergy and Immunology and the Oregon Society of Allergy, Asthma, and Immunology. He is currently President of the American College of Allergy, Asthma, and Immunology, and serves as a Board member of the American Board of Allergy and Immunology.
Read Less

Christopher Walsh

Christopher Walsh is a consulting professor to the Stanford University department of chemistry and an advisor to the Stanford ChEM-H institute. He was the Hamilton Kuhn Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School from 1987-2013 when he took emeritus status. He has had extensive academic leadership experience, including Chairmanship of the MIT Chemistry Dept (1982-1987) and of the HMS Biological Chemistry & Molecular Pharmacology Dept (1987-1995) as well as serving as President and CEO of the Dana Farber Cancer Institute (1992-1995).  His research has focused on enzymes and enzyme inhibitors, with specialization on antibiotics and biosynthesis of other biologically and medicinally active natural products. He and his group authored 810 research papers, and five books: on Enzymatic Reaction Mechanisms (1979); Antibiotics: Origins, Actions, Resistance (2003); Posttranslational Modification of Proteins: Expanding Nature’s Inventory (2005); Antibiotics: Challenges, Mechanisms, Opportunities (2016). Natural Product Biosynthesis: Chemical Logic and Enzymatic Machinery (2017).  He is a member of the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, the American Academy of Arts and Sciences, the American Philosophical Society, and a co-recipient of the 2010 Welch Prize in Chemistry. At Harvard and MIT he taught biochemistry, chemical biology, and pharmacology to medical students and graduate students and organic chemistry to undergraduates.  He has been involved in a variety of venture-based biotechnology companies since 1981, including Genzyme, Immunogen, Leukosite, Millenium, Kosan, Vicuron, Epizyme. Currently he is on the board of directors of Ironwood, and Proteostasis,  and the non profits: California Institute for Biomedical Research and The Scripps Research Institute. He is a member of the scientific advisory groups at Hua, Abide, Cidara, and Flex Pharma, an advisor to Health Care Ventures and a limited investor in Health Care Ventures, MPM bioventures, Clarus, and the Longwood Venture Funds.  Chris is married to Diana Chapman Walsh who was president of Wellesley College from 1993-2007 and was the founding chair of the board of the Broad Institute of MIT and Harvard (2009-2014). Their daughter Allison Walsh Kurian is an Associate Professor of Medicine at Stanford and co-director of the High Risk Center for women with genetic predisposition to breast and ovarian cancer.
Read Less

Kimberly Yates

Community Advisor
Kimberly Yates is the Special Advisor to Kari Nadeau and Public Relations Officer at the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She has partnered with Kari for the past 8 years working tirelessly to make the creation of the Center possible as well as ensure the research, therapies and diagnostics are publicized and have the resources necessary to come to fruition. As the parent of the first Multi Allergen Oral Immunotherapy patient she also serves as an ambassador throughout the country for the Center and the treatments being done at Stanford. Her leadership bridges philanthropy, community outreach and support and communications to make the Center’s vision a reality.
Read Less

Melanie Staggs

Community Advisor
Melanie Staggs is active in numerous philanthropic and nonprofit organizations.  She has served and currently serves on the boards of various organizations, including the California Community Foundation, Baby2Baby and Harvard-Westlake School and runs an annual Thanksgiving food drive feeding over 10,000 through Big Sunday.  She is the founder of "Thursday Night at the Movies," raising funds for food allergy research and education and currently serves on the National Advisory Board for the Sean N. Parker Center for Allergy and Asthma Research at Stanford.  Melanie is an advisor for Goodshop, an online coupon and shopping company that donates a percentage of every purchase to the purchaser's designated cause. She has also co-authored the early reader book "The Startup Club" intended to introduce children at a young age to basic financial and entrepreneurial concepts. She previously worked in corporate strategic planning and brand management for the Walt Disney Company and in new business development for The Disney Stores.  She holds a BA in economics and an MA in international policy studies from Stanford University as well as an MBA from the Stanford Graduate School of Business. She is a lifetime resident of Southern California and the proud mother of three boys.
Read Less